INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to oncology efficacy studies and early toxicity evaluations.
Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage.

This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities.

This next generation of in vivo efficacy and toxicity tests covers fours main aspects:
- EFFICACY assays for your anti-cancer treatments
- EARLY TOXICITY assays for your drug candidates
- TARGET VALIDATION in oncology
- MULTI-CANCER SCREENING to (re)positioning your treatment

We help chemists and biologists from companies and universities to validate a target and develop treatments by getting them through in vivo evaluation, while staying within their budget.
These accessible efficacy and toxicity assays open really new perspectives of screening for wide variety of project researches.